Loratadin-Teva Tablets 10 mg, # 30
Category
Allergy
Scope of the drug
Metabolism
Release form
Tablet
Manufacturer country
Hungary
Package quantity, pcs
thirty
Loratadin-Teva tab.
10 mg No. 30
Name ENG
LORATADINE TEVA
Clinical and pharmacological group
Blocker of histamine H1 receptors.
Antiallergic drug
ATX code
Loratadine
Dosage
10mg
Structure
Tablets 1 tab.
loratadine 10 mg
Indications
Symptomatic treatment of seasonal and perennial allergic rhinitis
chronic idiopathic urticaria
Contraindications
Hypersensitivity to loratadine and other components of the drug
lactose intolerance, lactase deficiency, glucose-galactose malabsorption
pregnancy
period of breastfeeding
children under 3 years old.
INN / Active ingredient
loratadine
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Allergy
Scope of the drug
Metabolism
Release form
Tablet
Manufacturer country
Hungary
Package quantity, pcs
thirty
Scope of application
Allergology
Minimum age from
2 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Teva
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
R06AX13 Loratadine
Dosage form
Pills
Packaging
Box
Expiration date in days
1095
The target audience
Children
Dosage (volume) of the substance in the preparation
1 tab.
loratadine 10 mg
Package weight, g
twenty
Mode of application
:
Inside for adults and children over 12 years old, as well as with a body weight of more than 30 kg - 10 mg 1 time / day.
Children from 2 to 12 years old with a body weight of less than 30 kg - 5 mg 1 time / day.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker